bemfola (development code: AFOLIA) is a recombinant-human Follicle-Stimulating Hormone (r-FSH) and has been developed as a biosimilar to Gonal-f®, an already-marketed and established reference product.
bemfola is the first product from Finox Biotech. Finox Biotech was founded 2007 in Switzerland and has since been working on implementing its vision to offer high quality, cost effective and patient friendly fertility products.
The bemfola app provides an iPad library containing patient information leaflets, user guide animations and user guide leaflets for bemfola as well as news on Finox Biotech.